THE BUSINESS announced two additions to the senior management team also.

THE BUSINESS announced two additions to the senior management team also. Simon S. Jones, Ph.D., was appointed Vice President, Biology and Preclinical Development and John H. Van Duzer, Ph.D., was appointed Vice President, Chemistry and Manufacturing. Acetylon can be applying its scientific knowledge to the advancement of little molecule HDAC inhibitors that build upon the proved therapeutic potential of HDAC inhibition with enhanced focus on selectivity.First-quarter results included favorable prior-period reserve development of $.29 per share, from fourth one fourth 2010 incurred healthcare costs primarily. First-quarter net income per share was $1.50. Bertolini. We are generating enjoyment in the marketplace about the integrated solutions that Aetna, Medicity and ActiveHealth Management bring to health care providers wanting to create Accountable Care Organizations . We expect the ACO relationship we lately set up with Carilion Clinic to become the first in some ACO announcements in the coming months.’ ‘Our budget, capital structure, and liquidity all continue being very strong,’ stated Joseph M. Zubretsky, senior executive vice CFO and president. ‘We have now project full-year 2011 operating earnings per share of $4.20 to $4.30.’ Health Care business results HEALTHCARE, which provides a full range of insured and self-insured medical, pharmacy, oral and behavioral health services and products, reported: Operating revenue of $555.3 million for the initial quarter of 2011, compared with $460.1 million for the corresponding period this year 2010.